| 000 | 01117 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512023139.0 | ||
| 264 | 0 | _c19860813 | |
| 008 | 198608s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(86)91957-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEvans, A E | |
| 245 | 0 | 0 |
_aSecondary prevention after myocardial infarction. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1986 |
||
| 300 |
_a150-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aCoronary Artery Bypass |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 | _aType A Personality |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8499 _gp. 150-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(86)91957-4 _zAvailable from publisher's website |
| 999 |
_c2879254 _d2879254 |
||